David Rosenbaum - Nov 4, 2024 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Development Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
Stock symbol
ARDX
Transactions as of
Nov 4, 2024
Transactions value $
-$161,673
Form type
4
Date filed
11/6/2024, 05:59 PM
Previous filing
Oct 1, 2024
Next filing
Nov 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Options Exercise $63K +27.2K +17.69% $2.32 181K Nov 4, 2024 By Wife F1
transaction ARDX Common Stock Sale -$162K -27.2K -15.03% $5.95 154K Nov 4, 2024 By Wife F1
holding ARDX Common Stock 302K Nov 4, 2024 Direct
holding ARDX Common Stock 77.6K Nov 4, 2024 Family Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDX Stock Option (Right to Buy) Options Exercise -$63K -27.2K -50% $2.32 27.2K Nov 4, 2024 Common Stock 27.2K $2.32 By Wife F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are directly held by the Reporting Person's wife.
F2 The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.
F3 The option became exercisable as it vested and the shares subject to the option vested in 48 successive, equal monthly installments on each monthly anniversary of January 17, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.